MEDS is a Swedish online pharmacy that helps people live healthier lives by offering rapid doorstep delivery, more attractive prices, wider product offering, and better opening hours. The company sets out to challenge incumbent physical-first pharmacies in the massive €5bn Swedish pharmacy products market, and beyond.
Björn Thorngren, CEO and co-founder of MEDS, commented: “This investment enables us to continue executing on our vision of delivering products and advice for health and well-being, whenever and wherever our customers need them. We are now perfectly positioned to capitalise on the rapid shift to online in the pharmacy market.”
Carl Wessberg, Partner at GP Bullhound, commented: ”With the acceleration of e-commerce on the back of social distancing, MEDS is truly a tailwind growth story that provides a sneak peek into what the future of pharmacy holds. It has been a true pleasure working with the MEDS team and we wish them the best of luck on the journey to come.”
This is further testament to GP Bullhound’s expertise in the Marketplaces sector, following previous transactions completed for Zedra (advised on sale of stake in The Hut Group), Baltic Classifieds Group (acquired by Apax Partners), and Autotrader (acquired by OLX, part of Naspers), among many others.
About GP Bullhound
GP Bullhound is a leading technology advisory and investment firm, providing transaction advice and capital to the world’s best entrepreneurs and founders. Founded in 1999, the firm today has offices in London, San Francisco, Stockholm, Berlin, Manchester, Paris, Hong Kong, Madrid and New York. For more information, please visit www.gpbullhound.com